ArticleCancer discovery2022

Tumor-Derived Lysophosphatidic Acid Blunts Protective Type I Interferon Responses in Ovarian Cancer.

Chang-Suk Chae et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.